Rearming the body’s immune system to fight cancer
We’re developing more precise and more accessible treatment alternatives for patients with solid cancers
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.
Some of our partners
Latest news
Good news from Cartherics
By Christine Filippis / March 25, 2020
Doctoral student Anisha Balachandran has submitted her thesis with compliments all-round By Leigh Dayton Image from Left to right :...
Read More
Cartherics and the Coronavirus
By Christine Filippis / March 24, 2020
A message from Cartherics CEO Alan Trounson 'Due to the escalation of public health measures to prevent the spread of...
Read More
Cartherics develops people as well as ideas
By Christine Filippis / March 20, 2020
Three cheers for PhD student Rasa Islam By Leigh Dayton, Cartherics Communication Advisor She started last March and now Cartherics’ first...
Read More
